1. The plaintiff's claim is dismissed.

2. The costs of lawsuit shall be borne by the Plaintiff.

1. Basic facts

A. On November 24, 2004, the Plaintiff entered into a mutual aid agreement (CI) with the Defendant, the Insured, and the beneficiaries as the Plaintiff on November 24, 2004, with the content that each of them pays KRW 75 million when serious cancer occurred during the first mutual aid period (the first time) and KRW 6 million when the diagnosis becomes final and conclusive as a sort of boundary. (hereinafter “instant mutual aid agreement”).

B. Under the instant mutual aid agreement, the term “serious cancer” refers to the form of malicious species that can be characterized by duplicating and destroying leapprophism of malicious cells in the surrounding organization, and the diagnosis and confirmation of cancer must be conducted by a doctor specializing in autopsy pathology or a person with a professional clinical pathology certificate, and this diagnosis must be based on organizational tests, suplicating tests, or blood tests, and only when it is not possible to perform such clinical diagnosis, the clinical diagnosis of cancer is admitted as evidence.

In addition, the boundaryal species are defined as an unknown behavior pattern or an unknown personal life, and it is stipulated that whether it falls under the category of Korean Standard Disease Disease Death Classification.

C. On July 28, 2014, the Plaintiff received crypt crypt crypt crypt crypt cryp cryp cryp cryp cryp cryp cryp cryp cryp cryp cryp cryp cryp cryp cryp cryp cryp cryp cryp cryp cryp cryp cryp cryp cryp cryp cryp cryp cryp cryp cryp cryp cryp cryp cryp cryp crypsa and subucoscsa cryp cryp cryp cryp cryp cryp cryp cryp cryp cryp cryp.

Based on this, on July 31, 2014, B Hospital Doctor D diagnosed the Plaintiff’s name of disease as “Galchobropo-cell species (Korean Disease Classification Number C20)” (Evidence No. 2).